Accuray To Participate at Stifel 2021 Virtual Healthcare Conference
Company to present on Tuesday, November 16th, 2021 at 6:20 am PT / 9:20 am ET
Get Alerts ARAY Hot Sheet
Join SI Premium – FREE
SUNNYVALE, Calif., Nov. 9, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in Stifel's 2021 Virtual Healthcare Conference. The management team is scheduled to present on Tuesday, November 16th, 2021 at 6:20 am PACIFIC / 9:20 am EASTERN.
The presentation to be delivered at the Stifel Healthcare Conference can be accessed on the Accuray website at https://investors.accuray.com following the conclusion of Management's talk. A replay of the webcast will be archived on the website for approximately 90 days.
About AccurayAccuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.
Investor ContactsLytham PartnersJoe Diaz+1 (602) 889-9660[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-participate-at-stifel-2021-virtual-healthcare-conference-301419456.html
SOURCE Accuray Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NEXT PROPERTIES ANNOUNCES RESULTS OF EXCHANGE OFFERS FOR ANY & ALL OF ITS OUTSTANDING 6.950% SENIOR NOTES DUE 2044 AND 6.390% SENIOR NOTES DUE 2050 FOR ADDITIONAL 7.731% SENIOR SUSTAINABILITY-LINK
- US Metro Bancorp Announces Third Quarter 2026 Results
- Pathalys Pharma Presents Positive Data from Pivotal Phase 3 Studies of Upacicalcet in Featured Oral Presentation at ASN Kidney Week 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stifel, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share